Connor, Clark & Lunn Investment Management Ltd. Agenus Inc Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$0.53 - $0.93 $197,515 - $346,584	372,671 New	372,671 $216,000
Q2 2022 Aug 05, 2022	SELL	$1.3 - $2.64 $37,546 - $76,248	-28,882 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.35 - $3.47 $67,872 - $100,220	28,882 New	28,882 $71,000
Q4 2021 Feb 10, 2022	SELL	$2.92 - $5.74 $2.73 Million - $5.36 Million	-934,007 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$4.98 - $6.63 $4.65 Million - $6.19 Million	934,007 New	934,007 $4.9 Million
Q2 2020 Aug 13, 2020	SELL	$2.29 - $4.24 $403,211 - $746,558	-176,075 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$1.92 - $4.39 $238,894 - $546,221	-124,424 Reduced 41.41%	176,075 $431,000
Q4 2019 Feb 12, 2020	BUY	$2.41 - $4.4 $678,607 - $1.24 Million	281,580 Added 1488.35%	300,499 $1.22 Million
Q3 2019 Nov 13, 2019	BUY	$2.17 - $3.14 $16,533 - $23,923	7,619 Added 67.42%	18,919 $49,000
Q2 2019 Aug 07, 2019	BUY	$2.53 - $3.04 $28,588 - $34,352	11,300 New	11,300 $34,000
Q1 2018 May 14, 2018	SELL	$3.51 - $6.04 $116,532 - $200,528	-33,200 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$3.26 - $4.78 $108,232 - $158,696	33,200	33,200 $108,000

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account